Targeted sequencing identifies novel GATA6 variants in a large cohort of patients with conotruncal heart defects
Targeted sequencing identifies novel GATA6 variants in a large cohort of patients with conotruncal heart defects
复制标题
靶向测序在一大群圆锥动脉干心脏缺陷患者中发现了新的 GATA6 变异
DOI:
10.1016/j.gene.2017.10.083
复制
发表时间:
2018
期刊:
影响因子:
3.5
通讯作者:
Sun Kun
中科院分区:
文献类型:
--
作者:
Zhang Erge;Hong Nanchao;Chen Sun;Fu Qihua;Li Fen;Yu Yu;Sun Kun
Studies have highlighted the critical role of GATA6 in conotruncal heart defects (CTDs). Nevertheless, relationship betweenGATA6variants and different CTDs remains largely unknown. HereGATA6gene was screened in 542 patients with CTDs using targeted sequencing. Variant frequency was 2.0% (11/542). Three novel variants: c.86C > A (p.A29E), c.296T > A (p.V99D) and c.1254delC (p.S418fs) were identified in patients with transposition of the great arteries, double outlet right ventricle and persistent truncus arteriosus, respectively, but in none of the 400 controls. Western blot revealed that A29E and V99D mutant protein had similar expression pattern with wild-typeGATA6protein, but S418fs mutant protein appeared as a truncated doublet. Reporter gene assay demonstrated that A29E and V99D mutant protein retained the ability to activate BNP and ANF promoter, whereas S418fs mutant protein failed to transactivate both of them, compared with wild-type. Subcellular localization of wild-type, A29E and V99D mutant protein were in the nucleus, while S418fs mutant protein was expressed both in the nucleus and cytoplasm. In conclusion,GATA6variant frequency in sporadic CTDs patients was higher than that in other congenital heart diseases. Variant c.1254delC was a pathogenic variant associated with CTDs, especially PTA, whereas c.86C > A and c.296T > A should be considered as likely pathogenic variants.